479 results on '"Loré, Karin"'
Search Results
2. Scifer: An R/Bioconductor package for large-scale integration of Sanger sequencing and flow cytometry data of index-sorted single cells
3. Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5.
4. Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
5. Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
6. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
7. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
8. Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
9. Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
10. A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
11. Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
12. Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
13. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
14. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
15. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
16. Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response
17. Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates
18. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
19. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
20. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
21. Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain
22. Comparative analysis of the germinal center response by flow cytometry and immunohistology
23. Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
24. Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques
25. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
26. Clonal Tracking of Rhesus Macaque Hematopoiesis Highlights a Distinct Lineage Origin for Natural Killer Cells
27. Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy.
28. Phenotyping of Myeloid-Derived Suppressor Cells in Nonhuman Primates
29. Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission
30. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
31. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
32. Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants
33. Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach
34. Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo
35. Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
36. Progress in vaccine development for infectious diseases : a Keystone Symposia report
37. Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
38. Progress in vaccine development for infectious diseases—a Keystone Symposia report
39. Cell targeting and immunostimulatory properties of a novel Fcγ-receptor independent agonistic anti-CD40 antibody in rhesus macaques
40. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial
41. Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques
42. Targeting Dendritic Cells for Improved HIV-1 Vaccines
43. Innate immune mechanisms of mRNA vaccines
44. Tissue Myeloid Cells in SIV-Infected Primates Acquire Viral DNA through Phagocytosis of Infected T Cells
45. Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression
46. Imaging the early fate of mRNA vaccines: VACCINES
47. Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants
48. AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitment
49. Plasmacytoid Dendritic Cells Infiltrate the Skin in Positive Tuberculin Skin Test Indurations
50. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.